Fig. 2From: Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen a PET/CT imaging (baseline / 6 weeks / 12 weeks) in a patient that developed complete clinical response; b MR imaging from the same patient at baseline and at 12 weeks after CRTBack to article page